Groupe Roski
19
4M
18
2.11
- Stages of investment
- Areas of investment
Summary
Groupe Roski appeared to be the VC, which was created in 2013.
We can highlight the next thriving fund investment areas, such as Health Care, Therapeutics. The fund has exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Hubba, Laurent Pharmaceuticals, Stratuscent. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Groupe Roski, startups are often financed by Brightspark Ventures, SOSV, RebelBio. The meaningful sponsors for the fund in investment in the same round are Anges Quu00e9bec Capital, Anges Quebec, Investissement Quebec. In the next rounds fund is usually obtained by Anges Quu00e9bec Capital, Anges Quebec, Sustainable Development Technology Canada.
The important activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The average startup value when the investment from Groupe Roski is 500 millions - 1 billion dollars. The fund is generally included in 2-6 deals every year.
Investments analytics
Analytics
- Total investments
- 19
- Lead investments
- 0
- Rounds per year
- 2.11
- Investments by industry
- Health Care (7)
- Biotechnology (5)
- Medical (3)
- Machine Learning (2)
- Computer (2) Show 44 more
- Investments by region
-
- Canada (17)
- United States (1)
- Peak activity year
- 2018
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 277M
- Group Appearance index
- 0.84
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| 4C Medical Technologies | 10 Sep 2018 | Health Care, Medical Device, Medical | Early Stage Venture | 17M | United States, Minnesota |
| My Intelligent Machines | 05 Sep 2019 | Biotechnology, Information Technology, Artificial Intelligence, Machine Learning, Health Care, Life Science, Bioinformatics, Clinical Trials | Seed | 2M | Quebec, Montreal, Canada |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.